Anil Kapur - 15 Oct 2024 Form 4 Insider Report for Nurix Therapeutics, Inc. (NRIX)

Role
Director
Signature
/s/ Daniel Burbach, as Attorney-in-Fact for Anil Kapur
Issuer symbol
NRIX
Transactions as of
15 Oct 2024
Net transactions value
$0
Form type
4
Filing time
16 Oct 2024, 16:48:38 UTC
Previous filing
20 Jun 2024
Next filing
19 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NRIX Director Stock Option (right to buy) Award $0 +50,000 $0.000000 50,000 15 Oct 2024 Common Stock 50,000 $24.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 1/36 of the total shares monthly beginning November 15, 2024, until the option is fully vested on October 15, 2027, subject to the Reporting Person's provision of service to the Issuer on each vesting date.